John Hamlin

801 total citations
11 papers, 432 citations indexed

About

John Hamlin is a scholar working on Epidemiology, Genetics and Surgery. According to data from OpenAlex, John Hamlin has authored 11 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 8 papers in Genetics and 2 papers in Surgery. Recurrent topics in John Hamlin's work include Microscopic Colitis (8 papers), Inflammatory Bowel Disease (8 papers) and Gastrointestinal motility and disorders (2 papers). John Hamlin is often cited by papers focused on Microscopic Colitis (8 papers), Inflammatory Bowel Disease (8 papers) and Gastrointestinal motility and disorders (2 papers). John Hamlin collaborates with scholars based in United Kingdom, United States and Canada. John Hamlin's co-authors include Alexander C. Ford, David J. Gracie, Michael Sprakes, Saqib Mumtaz, Ruchit Sood, Christopher J.M. Williams, Hassan Bholah, Mark A. Hull, Anthony O’Connor and C Mulatero and has published in prestigious journals such as Gastroenterology, Annals of the Rheumatic Diseases and The American Journal of Gastroenterology.

In The Last Decade

John Hamlin

11 papers receiving 429 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Hamlin United Kingdom 8 305 254 105 103 84 11 432
Francesca Bredin United Kingdom 7 364 1.2× 238 0.9× 38 0.4× 115 1.1× 216 2.6× 8 546
Francisco Fidencio Cons Molina Colombia 5 283 0.9× 235 0.9× 22 0.2× 95 0.9× 120 1.4× 8 414
Dhiman Basu United States 5 138 0.5× 157 0.6× 14 0.1× 58 0.6× 77 0.9× 7 304
Lisa Kaiser United States 9 95 0.3× 82 0.3× 14 0.1× 46 0.4× 58 0.7× 19 336
Jasmina Kalabic United States 13 243 0.8× 179 0.7× 13 0.1× 81 0.8× 177 2.1× 68 563
Fariborz Zandieh Iran 9 121 0.4× 53 0.2× 22 0.2× 52 0.5× 277 3.3× 25 391
I. Rumba Sweden 11 96 0.3× 36 0.1× 30 0.3× 109 1.1× 175 2.1× 20 404
Sami Evirgen Türkiye 10 116 0.4× 106 0.4× 41 0.4× 80 0.8× 22 0.3× 25 347
John O’Donohue United Kingdom 10 51 0.2× 148 0.6× 17 0.2× 103 1.0× 31 0.4× 19 325
Carole Collins United Kingdom 4 90 0.3× 29 0.1× 10 0.1× 52 0.5× 38 0.5× 9 250

Countries citing papers authored by John Hamlin

Since Specialization
Citations

This map shows the geographic impact of John Hamlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Hamlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Hamlin more than expected).

Fields of papers citing papers by John Hamlin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Hamlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Hamlin. The network helps show where John Hamlin may publish in the future.

Co-authorship network of co-authors of John Hamlin

This figure shows the co-authorship network connecting the top 25 collaborators of John Hamlin. A scholar is included among the top collaborators of John Hamlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Hamlin. John Hamlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
2.
Garcia‐Montoya, Leticia, Gabriele De Marco, Dennis McGonagle, et al.. (2019). AB0727 MAGNETIC RESONANCE IMAGING IN SYMPTOMATIC BACK PAIN IN INFLAMMATORY BOWEL DISEASE: STRUCTURAL LESIONS AND HLA-B27 IMPROVE THE DIAGNOSTIC ACCURACY IN AXIAL SPONDYLOARTHRITIS. Annals of the Rheumatic Diseases. 78. 1826–1827. 3 indexed citations
3.
Gracie, David J., John Hamlin, & Alexander C. Ford. (2018). Longitudinal impact of IBS-type symptoms on disease activity, healthcare utilization, psychological health, and quality of life in inflammatory bowel disease. The American Journal of Gastroenterology. 113(5). 702–712. 57 indexed citations
4.
Tinazzi, Ilaria, Christian Pagnoux, Adam V. Weizman, et al.. (2018). Emergence of severe spondyloarthropathy-related entheseal pathology following successful vedolizumab therapy for inflammatory bowel disease. Lara D. Veeken. 58(6). 963–968. 40 indexed citations
5.
Gracie, David J., Christopher J.M. Williams, Ruchit Sood, et al.. (2016). Poor Correlation Between Clinical Disease Activity and Mucosal Inflammation, and the Role of Psychological Comorbidity, in Inflammatory Bowel Disease. The American Journal of Gastroenterology. 111(4). 541–551. 121 indexed citations
6.
Brown, Peter, et al.. (2016). Relationship of Body Mass Index to Clinical Outcomes after Infliximab Therapy in Patients with Crohn’s Disease. Journal of Crohn s and Colitis. 10(10). 1144–1150. 27 indexed citations
7.
O’Connor, Anthony, Maria Marples, C Mulatero, John Hamlin, & Alexander C. Ford. (2016). Ipilimumab-induced colitis: experience from a tertiary referral center. Therapeutic Advances in Gastroenterology. 9(4). 457–462. 28 indexed citations
8.
Mohammed, Noor, Prashant Kant, Olorunda Rotimi, et al.. (2015). 446 High Definition White Light Endoscopy (Hdwle) Versus High Definition With Chromoendoscopy (Hdce) in the Detection of Dysplasia in Long Standing Ulcerative Colitis: a Randomized Controlled Trial. Gastrointestinal Endoscopy. 81(5). AB148–AB148. 27 indexed citations
9.
Sprakes, Michael, et al.. (2011). Efficacy, tolerability, and predictors of response to infliximab therapy for Crohn's disease: A large single centre experience. Journal of Crohn s and Colitis. 6(2). 143–153. 111 indexed citations
10.
Iacucci, Marietta, James O. Lindsay, Simon Campbell, et al.. (2010). Survey on the use of adalimumab as maintenance therapy in Crohn's disease in England and Ireland. European Journal of Gastroenterology & Hepatology. 22(3). 334–339. 12 indexed citations
11.
Sprakes, Michael, et al.. (2009). M1090 Infliximab Therapy Significantly Reduces Subsequent Disease-Related Costs in Crohn's Disease Patients: A 2-Year Follow-Up Study. Gastroenterology. 136(5). A–347. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026